Wu J, Williams GR, Branford-White C, Li H, Li Y, Zhu LM
The peptide was originally characterized by the Sikiric group at the University of Zagreb School of Medicine and has been investigated for over two decades in preclinical research models for its effects on tissue regeneration, angiogenesis, fibroblast migration, and cellular signaling across tendon, ligament, muscle, gastrointestinal, and vascular tissues
Following the FDA-approved titration schedules for each specific GLP-1 medication is important
BPC-157 Concerns FDA states that BPC-157 may present immunogenicity risks for certain routes because of aggregation and peptide-related impurities
(D) Bar graphs and dots summarize the number of -end (+) cells from DT-injected iDTR mice (black, n =4) and DT-injected iDTR:: Pomc -Cre mice (red, n =3)